Viking Therapeutics, Inc. (VKTX)
37.18
-0.17
(-0.46%)
USD |
NASDAQ |
Dec 26, 16:00
36.77
-0.41
(-1.10%)
Pre-Market: 08:59
Viking Therapeutics Long Term Notes Receivable (Quarterly)
Long Term Notes Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Non-current Note Receivables Definition
Non-current Note Receivables are the written obligations the creditors receive from the debtors in exchange for funds that are not due within the next twelve months. It is part of a company’s long term assets.
Long Term Notes Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Long Term Notes Receivable (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Pfizer Inc. | -- |
| Amgen, Inc. | -- |
| Altimmune, Inc. | -- |
| Moderna, Inc. | -- |